SG64919A1 - Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides - Google Patents
Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptidesInfo
- Publication number
- SG64919A1 SG64919A1 SG1996008589A SG1996008589A SG64919A1 SG 64919 A1 SG64919 A1 SG 64919A1 SG 1996008589 A SG1996008589 A SG 1996008589A SG 1996008589 A SG1996008589 A SG 1996008589A SG 64919 A1 SG64919 A1 SG 64919A1
- Authority
- SG
- Singapore
- Prior art keywords
- pct
- date
- pseudopeptides
- sec
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13882093A | 1993-10-15 | 1993-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG64919A1 true SG64919A1 (en) | 1999-05-25 |
Family
ID=22483811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996008589A SG64919A1 (en) | 1993-10-15 | 1994-10-17 | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5866685A (el) |
| EP (1) | EP0812205B1 (el) |
| JP (1) | JP3032297B2 (el) |
| KR (1) | KR100304332B1 (el) |
| CN (1) | CN1135717A (el) |
| AT (1) | ATE199727T1 (el) |
| AU (1) | AU703854B2 (el) |
| BG (1) | BG63166B1 (el) |
| BR (1) | BR9407839A (el) |
| CA (1) | CA2174097C (el) |
| CZ (1) | CZ291378B6 (el) |
| DE (1) | DE69426897T2 (el) |
| DK (1) | DK0812205T3 (el) |
| ES (1) | ES2155122T3 (el) |
| FI (1) | FI961634A (el) |
| GR (1) | GR3035581T3 (el) |
| HK (1) | HK1006225A1 (el) |
| HU (1) | HU222248B1 (el) |
| NO (1) | NO961460L (el) |
| NZ (1) | NZ275948A (el) |
| PL (1) | PL181749B1 (el) |
| PT (1) | PT812205E (el) |
| RO (1) | RO115520B1 (el) |
| RU (1) | RU2134695C1 (el) |
| SG (1) | SG64919A1 (el) |
| SK (1) | SK47796A3 (el) |
| UA (1) | UA44258C2 (el) |
| WO (1) | WO1995010295A1 (el) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3032297B2 (ja) * | 1993-10-15 | 2000-04-10 | ローヌ‐プーラン ローラー ファーマシューティカルズ インコーポレイテッド | 抗血栓性アザシクロアルキルアルカノイルペプチド及びプソイドペプチド |
| US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| US6274705B1 (en) * | 1996-05-02 | 2001-08-14 | Aventis Pharmaceuticals Products Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| BR9711340A (pt) * | 1996-08-21 | 1999-08-17 | Rhone Poulenc Rorer Pharma | Composto composi-Æo farmac-utica e processo para preparar um composto |
| KR100512671B1 (ko) * | 1996-11-27 | 2005-09-07 | 아벤티스 파마슈티칼스 인크. | 항 Ｘａ 활성을 지닌 화합물 및 혈소판 응집 길항제 화합물을포함하는 약제학적 조성물 |
| WO1999019294A1 (en) * | 1997-05-14 | 1999-04-22 | Aventis Pharmaceuticals Products Inc. Legal/Patents | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| CA2306823A1 (en) * | 1997-10-10 | 1999-04-22 | Aventis Pharmaceuticals Products Inc. | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| WO2000040601A1 (en) * | 1998-12-30 | 2000-07-13 | Aventis Pharmaceuticals Products Inc. | Process for preparing a stable non-hygroscopic crystalline n-[n-[n- piperdin- 4-yl)butanoyl)- n.ethylglycyl]- (l)-aspartyl] -ss-cyclohexylalanine amide |
| CN101735307B (zh) * | 2008-11-18 | 2012-05-30 | 北京航空航天大学 | 一种血小板膜糖蛋白寡肽或其修饰物/衍生物以及它们的应用 |
| RU2014153787A (ru) * | 2012-06-11 | 2016-08-10 | Дзе Кливленд Клиник Фаундейшн | Лечение и профилактика сердечно-сосудистого заболевания и тромбоза |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
| FR2608160B1 (fr) * | 1986-12-15 | 1989-03-31 | Inst Nat Sante Rech Med | Nouveaux derives peptidiques et leur application notamment en therapeutique |
| US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
| US4879313A (en) * | 1988-07-20 | 1989-11-07 | Mosanto Company | Novel platelet-aggregation inhibitors |
| US5037808A (en) * | 1988-07-20 | 1991-08-06 | Monsanto Co. | Indolyl platelet-aggregation inhibitors |
| US4992463A (en) * | 1988-07-20 | 1991-02-12 | Monsanto Company | Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation |
| US5023233A (en) * | 1989-07-28 | 1991-06-11 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| JPH05500954A (ja) * | 1989-09-29 | 1993-02-25 | ローヌ―プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド | 抗血栓性ペプチド及び疑似ペプチド |
| US5051405A (en) * | 1989-10-10 | 1991-09-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptides and pseudopeptides |
| US5064814A (en) * | 1990-04-05 | 1991-11-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
| IL99539A0 (en) * | 1990-09-27 | 1992-08-18 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical compositions containing them |
| AU661659B2 (en) * | 1991-04-11 | 1995-08-03 | Rhone-Poulenc Rorer International (Holdings) Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
| JP3032297B2 (ja) * | 1993-10-15 | 2000-04-10 | ローヌ‐プーラン ローラー ファーマシューティカルズ インコーポレイテッド | 抗血栓性アザシクロアルキルアルカノイルペプチド及びプソイドペプチド |
-
1994
- 1994-10-17 JP JP7512250A patent/JP3032297B2/ja not_active Expired - Fee Related
- 1994-10-17 AT AT95900403T patent/ATE199727T1/de not_active IP Right Cessation
- 1994-10-17 CZ CZ19961084A patent/CZ291378B6/cs not_active IP Right Cessation
- 1994-10-17 US US08/628,648 patent/US5866685A/en not_active Expired - Lifetime
- 1994-10-17 CN CN94194242A patent/CN1135717A/zh active Pending
- 1994-10-17 SK SK477-96A patent/SK47796A3/sk unknown
- 1994-10-17 HU HU9600983A patent/HU222248B1/hu not_active IP Right Cessation
- 1994-10-17 BR BR9407839A patent/BR9407839A/pt not_active Application Discontinuation
- 1994-10-17 UA UA96051845A patent/UA44258C2/uk unknown
- 1994-10-17 DE DE69426897T patent/DE69426897T2/de not_active Expired - Lifetime
- 1994-10-17 NZ NZ275948A patent/NZ275948A/en unknown
- 1994-10-17 SG SG1996008589A patent/SG64919A1/en unknown
- 1994-10-17 WO PCT/US1994/012135 patent/WO1995010295A1/en active IP Right Grant
- 1994-10-17 EP EP95900403A patent/EP0812205B1/en not_active Expired - Lifetime
- 1994-10-17 DK DK95900403T patent/DK0812205T3/da active
- 1994-10-17 RO RO96-00812A patent/RO115520B1/ro unknown
- 1994-10-17 RU RU96109375/04A patent/RU2134695C1/ru not_active IP Right Cessation
- 1994-10-17 AU AU81237/94A patent/AU703854B2/en not_active Ceased
- 1994-10-17 KR KR1019960701992A patent/KR100304332B1/ko not_active IP Right Cessation
- 1994-10-17 PL PL94313975A patent/PL181749B1/pl unknown
- 1994-10-17 ES ES95900403T patent/ES2155122T3/es not_active Expired - Lifetime
- 1994-10-17 CA CA002174097A patent/CA2174097C/en not_active Expired - Fee Related
- 1994-10-17 PT PT95900403T patent/PT812205E/pt unknown
-
1996
- 1996-04-12 FI FI961634A patent/FI961634A/fi unknown
- 1996-04-12 NO NO961460A patent/NO961460L/no not_active Application Discontinuation
- 1996-04-26 BG BG100544A patent/BG63166B1/bg unknown
-
1998
- 1998-06-16 HK HK98105458A patent/HK1006225A1/xx not_active IP Right Cessation
-
2001
- 2001-03-15 GR GR20010400194T patent/GR3035581T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU93054168A (ru) | Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе | |
| WO2001078709A3 (en) | Treatment of neurodegenerative disease | |
| BG103521A (en) | Substituted pyrimidinon and pyridon compounds and methods for their application | |
| FR2699077B1 (fr) | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. | |
| CA2288143A1 (en) | Activated protein c formulations | |
| IL112111A (en) | Peptides having growth hormone releasing properties and pharmaceutical compositions containing them | |
| HK1006225A1 (en) | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | |
| UA26973A1 (uk) | Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів | |
| DE69521536D1 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| EP1538163A3 (en) | Phosphorylated Amyloid-Beta 1-43 Protein and its use in the treatment of Alzheimer's disease | |
| SG67928A1 (en) | Antithrombotic | |
| BG103512A (en) | Substituted pyramidine compounds and their application | |
| MXPA03011502A (es) | Aminoalcoholes sustituidos utiles en tratamiento de enfermedad de alzheimer. | |
| CA2140010A1 (en) | Blood coagulation normalizer containing tcf-ii as active ingredient | |
| CA2179857A1 (en) | Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury | |
| BG102079A (en) | Alkylaminoderivatives of substituted quinoxalin-2,3-dions such as glutamatereceptor antagonists | |
| CA2065889A1 (en) | Increasing the choroidal blood flow | |
| CA2135752A1 (en) | Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease | |
| GR3031254T3 (en) | Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same | |
| ES2058025A1 (es) | Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica. | |
| CA2060333A1 (en) | Use of pyrimido-benzothiazine derivatives | |
| RU95104302A (ru) | Аппликационный материал лечебно-профилактического назначения | |
| IT1264562B1 (it) | Composizione farmaceutica per l'applicazione topica di 17,b estradiolo nel trattamento della cheratocongiuntivite sicca |